Trial · NCT00422058
Adverse events546
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 546
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Palpitations | Cardiac disorders | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | 0 | 98 | 0 |
| other | Palpitations | Cardiac disorders | Lira 1.2 mg/Lira 3.0 mg | 0 | 95 | 0 |
| other | Palpitations | Cardiac disorders | Lira 1.8 mg/Lira 3.0 mg | 6 | 90 | 6 |
| other | Palpitations | Cardiac disorders | Lira 2.4 mg/Lira 3.0 mg | 0 | 93 | 0 |
| other | Palpitations | Cardiac disorders | Liraglutide 3.0 mg | 0 | 93 | 0 |
| other | Palpitations | Cardiac disorders | Orlistat | 0 | 95 | 0 |
| other | Vertigo | Ear and labyrinth disorders | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | 0 | 98 | 0 |
| other | Vertigo | Ear and labyrinth disorders | Lira 1.2 mg/Lira 3.0 mg | 0 | 95 | 0 |
| other | Vertigo | Ear and labyrinth disorders | Lira 1.8 mg/Lira 3.0 mg | 0 | 90 | 0 |
| other | Vertigo | Ear and labyrinth disorders | Lira 2.4 mg/Lira 3.0 mg | 0 | 93 | 0 |
| other | Vertigo | Ear and labyrinth disorders | Liraglutide 3.0 mg | 0 | 93 | 0 |
| other | Vertigo | Ear and labyrinth disorders | Orlistat | 5 | 95 | 5 |
| other | Abdominal distension | Gastrointestinal disorders | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | 5 | 98 | 5 |
| other | Abdominal distension | Gastrointestinal disorders | Lira 1.2 mg/Lira 3.0 mg | 5 | 95 | 5 |
| other | Abdominal distension | Gastrointestinal disorders | Lira 1.8 mg/Lira 3.0 mg | 0 | 90 | 0 |
| other | Abdominal distension | Gastrointestinal disorders | Lira 2.4 mg/Lira 3.0 mg | 0 | 93 | 0 |
| other | Abdominal distension | Gastrointestinal disorders | Liraglutide 3.0 mg | 0 | 93 | 0 |
| other | Abdominal distension | Gastrointestinal disorders | Orlistat | 0 | 95 | 0 |
| other | Abdominal pain | Gastrointestinal disorders | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | 6 | 98 | 6 |
| other | Abdominal pain | Gastrointestinal disorders | Lira 1.2 mg/Lira 3.0 mg | 0 | 95 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00422058/events